The Patent Finder

Xenova Limited

Also on record
Records under this name other than patents Xenova Limited holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.

Back to Xenova Limited

Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleStatus Expires Confidence
US 6,218,393Anthranilic acid derivatives as multi drug resistance modulators
Term ended
Term ended Jun 9, 2019 · USPTO record
Term endedTerm ended Jun 9, 2019USPTO record
US 6,054,127Hapten-carrier conjugates for use in drug-abuse therapy and methods for preparation of same
Term ended
Term ended Jun 27, 2017 · USPTO record
Term endedTerm ended Jun 27, 2017USPTO record
US 7,524,861Process for the preparation of a hydrate of an anthranilic acid derivative
Lapsed on the fee record
Ended Apr 28, 2017 · USPTO record
Lapsed on the fee recordEnded Apr 28, 2017USPTO record
US 6,552,021Pharmaceutical compounds
Lapsed on the fee record
Ended Apr 22, 2015 · USPTO record
Lapsed on the fee recordEnded Apr 22, 2015USPTO record
US 6,114,332Bis(acridinecarboxamide) and bis(phenazinecarboxamide) as antitumor agents
Lapsed on the fee record
Ended Sep 5, 2012 · USPTO record
Lapsed on the fee recordEnded Sep 5, 2012USPTO record
US 6,784,203Cytokine Production Inhibitors
Formerly held
Lapsed on the fee record
Ended Aug 31, 2012 · High confidence
Lapsed on the fee recordEnded Aug 31, 2012High confidence
US 6,057,315Antibacterial agents
Formerly held
Lapsed on the fee record
Ended May 2, 2012 · USPTO record
Lapsed on the fee recordEnded May 2, 2012USPTO record
US 7,132,419Pharmaceutical compounds
Lapsed on the fee record
Ended Nov 7, 2010 · USPTO record
Lapsed on the fee recordEnded Nov 7, 2010USPTO record
US 6,518,316Cytokine production and tyrosine kinase inhibitors
Lapsed on the fee record
Ended Feb 11, 2007 · USPTO record
Lapsed on the fee recordEnded Feb 11, 2007USPTO record
US 6,111,109Process for the preparation of N-[2-(dimethylamino)ethyl]acridine-4-carboxamide
Lapsed on the fee record
Ended Aug 29, 2004 · USPTO record
Lapsed on the fee recordEnded Aug 29, 2004USPTO record
10 of 27 patents shown.
Pro members see all 27.
Pro members: see all 27 patents
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 19, 2026 · includes USPTO assignment data published Nov 18, 2026, status data published Nov 19, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited